Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease
The Clinical Respiratory Journal · 2025
DOI: 10.1111/crj.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Clinical Respiratory Journal, 2025. Verfasst von Ebru Sengul Parlak und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chest Diseases, Ankara Bilkent City Hospital, Ankara, Türkiye. Hauptthemen laut MEDLINE: Pulmonary Embolism, Hypertension, Pulmonary. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The objective of this study was to examine the development of chronic thromboembolic pulmonary disease (CTEPD) incidence, risk factors, and coexisting medical conditions following an episode of acute pulmonary embolism (PE). Materials This retrospective, cross‐sectional study analyzed data from 722 patients diagnosed with PE. Group I ( n = 663), consisting of individuals who did not develop CTEPD, and Group II ( n = 59), comprising those who progressed to CTEPD. CTEPD were divided into two subgroups as chronic thromboembolic pulmonary hypertension (CTEPH, n = 23) and without pulmonary hypertension (PH) ( n = 36). The groups were compared based on demographic features, comorbid conditions, risk factors, and initial systolic pulmonary artery pressure (sPAP) values.
Results
CTEPD was observed in 59 patients (8.2%). Chronic obstructive pulmonary disease, coronary artery disease, and elevated baseline sPAP demonstrated a significant association with CTEPD ( p = 0.003, p = 0.041, and p = 0.024, respectively). Immobilization was found to be significantly more prevalent in Group I ( p = 0.032). In the multivariate logistic regression analysis, each 1 mmHg increase in baseline sPAP was associated with a 1.04‐fold elevation in the risk of CTEPD development (95% confidence interval [CI]: 1.02–1.05; p < 0.001). Additionally, a 1‐year decrease in age was linked to a 1.03‐fold increase in the probability of developing CTEPD (95% CI: 1.01–1.05; p = 0.003). No significant differences were found between patients with CTEPH and those with CTEPD without PH.
Conclusion
These findings highlight the important role of comorbid conditions in the development of CTEPD. It is important to optimize the clinical management of patients with such comorbidities to reduce the risk of CTEPD development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Chest Diseases, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Department of Cardiology, Ankara Bilkent City Hospital, Ankara, Türkiye.
- Department of Radiology, Ankara Bilkent City Hospital, Ankara, Türkiye.
ORCID-Profile: Ebru Sengul Parlak, Beyza Aybuke Aydin Uzun, Kubra Gungor, Eren Goktug Ceylan, Kubra Isik, Rabia Damla Kiziltas, Dina Serin, Umran Ozden Sertcelik, Serdal Bastug, Zeynep Hande Kocaer, Derya Sokmen, Izzet Selcuk Parlak, Ayşegül Karalezli
Zitieren
APA
Parlak, E. S., Uzun, B. A. A., Gungor, K., Ceylan, E. G., Isik, K., Kiziltas, R. D., Serin, D., Sertcelik, U. O., Bastug, S., Kocaer, Z. H., Sokmen, D., Parlak, I. S., & Karalezli, A. (2025). Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70147
Vancouver
Parlak ES, Uzun BAA, Gungor K, Ceylan EG, Isik K, Kiziltas RD, et al. Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease. The Clinical Respiratory Journal. 2025. doi:10.1111/crj.70147
BibTeX
@article{Parlak2025,
author = {Parlak, Ebru Sengul and Uzun, Beyza Aybuke Aydin and Gungor, Kubra and Ceylan, Eren Goktug and Isik, Kubra and Kiziltas, Rabia Damla and Serin, Dina and Sertcelik, Umran Ozden and Bastug, Serdal and Kocaer, Zeynep Hande and Sokmen, Derya and Parlak, Izzet Selcuk and Karalezli, Ayşegül},
title = {Evaluation of Predisposing Factors and Coexisting Diseases in the Development of Chronic Thromboembolic Pulmonary Disease},
journal = {The Clinical Respiratory Journal},
year = {2025},
doi = {10.1111/crj.70147}
}
EUVIMED